The Claim
In human diabetic nephropathy, the expression of ATF4 and p16 is significantly elevated in renal tubular epithelial cells and is positively correlated with the deposition of advanced glycation end products.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with diabetic kidney disease, higher levels of ATF4 and p16 proteins in kidney tubule cells are consistently found alongside increased deposits of advanced glycation end products.
See the scientific wording
In human diabetic nephropathy, the expression of ATF4 and p16 is significantly elevated in renal tubular epithelial cells and correlates positively with the deposition of advanced glycation end products, suggesting a potential link between metabolic stress and cellular aging in the kidney.
High blood sugar causes harmful sugar-coated proteins to build up in kidney cells, which stresses the cell's internal protein-folding system. This stress turns on a specific signal that increases a protein called ATF4, which then turns on another protein called p16. P16 stops the cells from dividing, forcing them into a permanent aging state that damages kidney tissue.
What the research says
1 studyIn people with diabetic kidney disease, sugar-damaged proteins (AGEs) build up in kidney cells, and this is linked to higher levels of two proteins—ATF4 and p16—that are signs of aging in cells. The study found that when AGEs go up, so do these aging proteins, and blocking them reduces cell aging.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.